The shoes would monitor wearers’ movement, weight and falls, people familiar with the project told the publication. Verily has reportedly shown potential partners a prototype of the shoe, but it’s unclear whether the project is still active.
Health-tracking shoes could be used to identify sudden weight gain — a change that’s sometimes indicative of water retention, a symptom of congestive heart failure, CNBC suggests.
Verily did not respond to CNBC’s request for comment. Other projects Verily is working on include a stabilizing spoon, a smartwatch for clinical research and “smart” contact lenses.
More articles on health IT:
Epic’s MyChart earns ‘Best in KLAS’ for patient portals
Athenahealth adds HIPAA risk analysis tool to EHR app store
2 ways Apple is promoting heart month in February
